Search for a report

EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

The Europe pharmaceutical continuous manufacturing market is estimated to project a CAGR of 9.97% during the forecast period, 2021-2028. The growing demand for technologically advanced systems, the availability of innovative continuous manufacturing systems, and the increasing preference for continuous manufacturing, are set to propel market growth.

EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

Europe Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous System, Semi-continuous System, Control & Software) by Application (Final Drug Product Manufacturing, Api Manufacturing) by End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Other End-users) and by Geography

Request free sample

The Europe pharmaceutical continuous manufacturing market is estimated to project a CAGR of 9.97% during the forecast period, 2021-2028. The growing demand for technologically advanced systems, the availability of innovative continuous manufacturing systems, and the increasing preference for continuous manufacturing, are set to propel market growth.
europe-pharmaceutical-continuous-manufacturing-market

To know more about this report, request a free sample copy

The United Kingdom, Russia, Germany, Italy, Poland, Belgium, France, and Rest of Europe, are evaluated for the Europe pharmaceutical continuous manufacturing market growth assessment. The United Kingdom houses two of the largest pharmaceutical companies in the world, AstraZeneca and GlaxoSmithKline. The high per capita income and the well-developed healthcare infrastructure of the UK are beneficial to market growth. There has also been an increase in pharmaceutical expenditure. Several of the world’s biggest-selling prescription drugs are developed in the UK. Further, the collaborations between the major market players and government initiatives are estimated to drive the UK market growth. In Italy, the pharmaceutical industry supplements the economic growth. The country is also one of the leading pharmaceutical producers in the European Union. Moreover, the pharmaceutical industry of the country is export-oriented. There has also been a growing dependency on foreign markets, with export values of pharmaceuticals surging in recent years. Research and development are highly-prioritized in the pharmaceutical sector. Such factors are projected to increase the market growth in Italy.

Siemens Healthineers AG manufactures medical, ophthalmic, veterinary, and surgical instruments and apparatus with full-spectrum diagnostics, imaging, advanced therapies, and services. The company is a market leader with regard to imaging systems. Its operational regions include Europe, Asia, the Middle East, and Africa. The company is headquartered in Erlangen, Germany.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      •    KEY DRIVERS
        • INCREASED ADOPTION OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
        • RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING SYSTEMS
        • RISE IN PRODUCTION OF LARGE MOLECULES AND BIOLOGICS
        • INCREASE IN HEALTHCARE EXPENDITURE
      •    KEY RESTRAINTS
        • INCREASING CUSTOMER ANTICIPATIONS
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCE ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY PRODUCT
      • INTEGRATED CONTINUOUS SYSTEM
      • SEMI-CONTINUOUS SYSTEM
      • CONTROL & SOFTWARE
    3. MARKET BY APPLICATION
      • FINAL DRUG PRODUCT MANUFACTURING
      • API MANUFACTURING
    4. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT MANUFACTURING ORGANIZATIONS
      • OTHER END-USERS
    5. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • COPERION GMBH
        • ELI LILLY & COMPANY
        • GEA GROUP AG
        • GEBRUDER LODIGE MASCHINENBAU GMBH
        • GLATT GMBH
        • HOSOKAWA MICRON CORPORATION
        • KORSCH AG
        • LB BOHLE MASCHINEN + VERFAHREN GMBH
        • MUNSON MACHINERY COMPANY
        • PFIZER INC
        • SIEMENS HEALTHINEERS
        • SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
        • THERMO FISHER SCIENTIFIC INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL CONTINUOUS MANUFACTURING

    TABLE 2: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

    FIGURES LIST

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, IN 2020

    FIGURE 6: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, IN 2020

    FIGURE 10: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, IN 2020

    FIGURE 13: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 17: GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 18: FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 19: UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 20: ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 21: RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: BELGIUM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: REST OF EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY PRODUCT
      • INTEGRATED CONTINUOUS SYSTEM
      • SEMI-CONTINUOUS SYSTEM
      • CONTROL & SOFTWARE
    2. MARKET BY APPLICATION
      • FINAL DRUG PRODUCT MANUFACTURING
      • API MANUFACTURING
    3. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT MANUFACTURING ORGANIZATIONS
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now